Interleukin-10 and interferon-gamma cytokine gene polymorphisms may be risk factors for chronic myelogenous leukemia

Turkish Journal of Haematology

Volumn 22, Issue 4, 2005, Pages 191-196

  Baştürk, Bilkay ^a   Evke, Elif ^b   Tunali, Ahmet ^b   Karakuş, Sema ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chronic myelogenous leukemia; Cytokines; Gene polymorphisms; PCR

Indexed keywords

GAMMA INTERFERON; GENOMIC DNA; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 33144474686     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-3.
2. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985;315:550-4.
3. Keen LJ. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002;10:143-6.
4. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
5. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Laundy GJ. Human cytokine gene nucleotide sequence alignments. 1998. Eur J Immunogenet 1998; 25:83-265.
6. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-γ correlates with CA repeat polymorphism in IFN-γ gene. Eur J Immunogenet 1999;26:1-3.
7. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the IL-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
8. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
9. Awad MR, Webber S, Boyle G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001;20: 625-30.
10. Nakagoe T, Tsuji T, Sawai T, Tanaka K, Hidika S, Shibasaki S, Nanoshima A, Yamaguchi H, Yasutake T, Sugawara K, Inokuchi N, Kamihira S. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer. Anticancer Res 2003;23:3561-4.
11. Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 2003;83:222-6.
12. Kantarci OH, Schaefer-Klein JL, Hebrink DD, Achenbach SJ, Atkinson EJ, McMurray CT, Weinshenker BG. A population-based study of IL-4 polymorphisms in multiple sclerosis. J Neuroimmunol 2003;137:134-9.
13. Karasu Z, Ulukaya S, Ayanoglu HO, Basturk B, Ulukaya E, Akyildizli M, Tokat Y. Cytokine gene polymorphism and early graft rejection in liver transplant recipients. Transplant Proc 2004;36: 2791-5.
14. Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K. Pneumococcal septic shock is associated with the interleukin-10 -1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003;168:476-80.
15. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 2003;4:234-8.
16. Hegele A, Varga Z, von Knobloch R, Heidenreich A, Kropf J, Hofmann R. TGF-beta 1 in patients with renal cell carcinoma. Urol Res 2002;30:126-9.
17. Aswald JM, Lipton JH, Messner HA. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia. Cytokines Cell Mol Ther 2002;7:75-82.
18. Ikeda H, Old LJ, Schreiber RD. The roles IFN-γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13:95-109.
19. Reuben JM, Lee BN, Johnson H, Fritsche H, Kantarjian HM, Talpaz M. Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha. Clin Cancer Res 2000;6:1671-7.
20. Aswald JM, Lipton JH, Aswald S, Messner HA. Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukaemia. Cytokines Cell Mol Ther 2002;7:143-9.
21. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
22. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-8.
23. Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002;168: 1968-77.
24. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3:944-50.
25. Palma JP, Yauch RL, Kang HK, Lee HG, Kim BS. Preferential induction of IL-10 in APC correlates with a switch from Th1 to Th2 response following infection with a low pathogenic variant of Theiler's virus. J Immunol 2002;168:4221-30.
26. Pawelec G, Schlotz E, Rehbein A. IFN-alpha regulates IL 10 production by CML cells in vitro. Cancer Immunol Immunother 1999;48:430-4.